Try our beta test site

Phase 1-2 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
ImmunoVaccine Technologies, Inc. Identifier:
First received: August 9, 2011
Last updated: December 14, 2015
Last verified: December 2015